Surendralal Lanca Karsanbhai Emerson Electric CO (EMR) insider trading activity

Surendralal Lanca Karsanbhai is President & CEO of EMERSON ELECTRIC CO. Currently has a direct ownership of 193,172 shares of EMR, which is worth approximately $24.6 Million. The most recent transaction as insider was on Dec 15, 2025, when has been sold 3,120 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 193K

6.19% 3M change

6.19% 12M change

Total Value Held $24.6 Million

Surendralal Lanca Karsanbhai Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2025	SELL Bona fide gift	-	3,120 Reduced 1.59%	193,172 Common Stock
Dec 03 2025	SELL Payment of exercise price or tax liability	$394,212 $133.0 p/Share	2,964 Reduced 1.44%	203,555 Common Stock
Dec 03 2025	SELL Open market or private sale	$965,979 $133.0 p/Share	7,263 Reduced 3.57%	196,292 Common Stock
Dec 03 2025	BUY Exercise of conversion of derivative security	$465,328 $45.5 p/Share	10,227 Added 4.72%	206,519 Common Stock
Dec 02 2025	SELL Payment of exercise price or tax liability	$217,220 $131.41 p/Share	1,653 Reduced 0.84%	196,292 Common Stock
Dec 02 2025	BUY Exercise of conversion of derivative security	$217,171 $45.5 p/Share	4,773 Added 2.35%	197,945 Common Stock
Nov 25 2025	SELL Bona fide gift	-	115,705 Reduced 37.46%	193,172 Common Stock

Nov 06 2025	SELL Payment of exercise price or tax liability	$1,329,223 $132.71 p/Share	10,016 Reduced 3.14%	308,877 Common Stock
Nov 04 2025	SELL Payment of exercise price or tax liability	$1,247,832 $138.31 p/Share	9,022 Reduced 2.75%	318,893 Common Stock
Nov 03 2025	SELL Payment of exercise price or tax liability	$10,049,627 $139.46 p/Share	72,061 Reduced 20.86%	273,440 Common Stock
Nov 03 2025	BUY Grant, award, or other acquisition	-	218,063 Added 39.94%	327,915 Common Stock
Dec 17 2024	SELL Bona fide gift	-	12,698 Reduced 6.52%	181,913 Common Stock
Nov 07 2024	SELL Bona fide gift	-	72,282 Reduced 27.08%	194,611 Common Stock
Nov 06 2024	SELL Payment of exercise price or tax liability	$1,259,166 $125.44 p/Share	10,038 Reduced 3.62%	266,893 Common Stock
Nov 04 2024	SELL Payment of exercise price or tax liability	$6,234,545 $109.11 p/Share	57,140 Reduced 20.96%	215,490 Common Stock
Nov 04 2024	BUY Grant, award, or other acquisition	-	190,863 Added 40.8%	276,931 Common Stock
Jun 28 2024	SELL Bona fide gift	-	542 Reduced 0.39%	138,208 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$118,061 $105.98 p/Share	1,114 Reduced 0.78%	141,094 Common Stock
Feb 14 2024	SELL Open market or private sale	$248,510 $106.02 p/Share	2,344 Reduced 1.66%	138,750 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	$251,360 $62.84 p/Share	4,000 Added 2.74%	142,208 Common Stock
Nov 10 2023	SELL Bona fide gift	-	67,655 Reduced 32.86%	138,208 Common Stock
Nov 06 2023	BUY Grant, award, or other acquisition	-	130,863 Added 38.86%	205,863 Common Stock
Dec 01 2022	SELL Bona fide gift	-	1,475 Reduced 1.93%	75,000 Common Stock
Nov 16 2022	SELL Open market or private sale	$441,243 $95.86 p/Share	4,603 Reduced 4.42%	99,591 Common Stock
Nov 16 2022	SELL Payment of exercise price or tax liability	$375,531 $95.75 p/Share	3,922 Reduced 3.91%	96,449 Common Stock

Also insider at

MRK

Merck & Co., Inc. Healthcare

Director

SLK